Misappropriation of the 1986 WHO analgesic ladder: The pitfalls of labelling opioids as weak or strong
Lobo, Dileep N.
Lobo, Dileep N.
Abstract
Opioids have a vital role in alleviating pain from cancer and surgery. Despite good intentions, it is now recognised that the original WHO Cancer Pain Relief guidance from 1986, in which opioids were classified as either weak or strong, has been both inadvertently and purposefully misused, thereby contributing to harm from opioid use and misuse. However, the recommendation in the 2018 update of the WHO analgesic ladder that a combination of a high-potency opioid with simple analgesics is better than alternative analgesics for the maintenance of pain relief is also applicable to patients who require short-term opioids. Furthermore, because potential harm through opioid use and misuse is intrinsic to all opioids, whether weak or strong, we argue that the arbitrary classification of opioids either as weak or strong should be discontinued, as this description is not helpful to either prescribers or consumers. Copyright © 2022 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.
MIDER Authors
Citations
Altmetric:
Date
2022
Type
Article
Subject
Collections
Citation
Crush, J., Levy, N., Knaggs, R.D. and Lobo, D.N. (2022) 'Misappropriation of the 1986 WHO analgesic ladder: The pitfalls of labelling opioids as weak or strong', British Journal of Anaesthesia, 129(2), pp. 137-142. doi: 10.1016/j.bja.2022.03.004 https://doi.org/10.1016/j.bja.2022.03.004.
Journal / Source Title
DOI
PMID
Publisher
Publisher’s URL
Publisher’s statement
Available to read on the publisher's website here: https://doi.org/10.1016/j.bja.2022.03.004.